Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Brain Insulin Sensitivity in Prediabetes
NCT03227484Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Jun 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in prediabetes, sponsored by University Hospital Tübingen. Started Jun 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT03227484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227484.